Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Apple
AAPL
|
+$763M |
| 2 |
Amazon
AMZN
|
+$688M |
| 3 |
TSMC
TSM
|
+$562M |
| 4 |
Tesla
TSLA
|
+$419M |
| 5 |
Johnson & Johnson
JNJ
|
+$398M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
Novo Nordisk
NVO
|
+$366M |
| 4 |
JPMorgan Chase
JPM
|
+$335M |
| 5 |
ASML
ASML
|
+$325M |
Sector Composition
| 1 | Healthcare | 20.8% |
| 2 | Technology | 15.52% |
| 3 | Consumer Discretionary | 11.85% |
| 4 | Consumer Staples | 10.11% |
| 5 | Financials | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3601
Key Tronic
KTCC
$37M
| $106K | ﹤0.01% |
24,400
+7,573
| +45% | +$32.9K |
|
3602
Titan Pharmaceuticals
TTNP
$5.76M
| $105K | ﹤0.01% |
6,721
-515
| -7% | -$8.05K |
|
3603
Asia Pacific Wire & Cable
APWC
$41.9M
| $104K | ﹤0.01% |
72,000
-7,000
| -9% | -$10.1K |
|
3604
Ebang International Holdings
EBON
$26.9M
| $104K | ﹤0.01% |
35,613
+1,776
| +5% | +$5.19K |
|
3605
Gain Therapeutics
GANX
$60.4M
| $104K | ﹤0.01% |
33,200
-200
| -0.6% | -$627 |
|
3606
CareCloud
CCLD
$161M
| $103K | ﹤0.01% |
36,500
+600
| +2% | +$1.69K |
|
3607
Flora Growth
FLGC
$14M
| $103K | ﹤0.01% |
580
+220
| +61% | +$39.1K |
|
3608
Greenidge Generation Holdings
GREE
$22.4M
| $103K | ﹤0.01% |
35,645
+4,765
| +15% | +$13.8K |
|
3609
Direct Digital Holdings
DRCT
$9.32M
| $102K | ﹤0.01% |
42,000
+28,800
| +218% | +$69.9K |
|
3610
Entera Bio
ENTX
$83.6M
| $102K | ﹤0.01% |
139,600
+118,300
| +555% | +$86.4K |
|
3611
Veritone
VERI
$213M
| $102K | ﹤0.01% |
19,200
-16,700
| -47% | -$88.7K |
|
|
CZOO
3612
DELISTED
Cazoo Group Ltd
CZOO
| $102K | ﹤0.01% |
324
+164
| +103% | +$51.6K |
|
|
SRGA
3613
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $102K | ﹤0.01% |
51,452
-7,218
| -12% | -$14.3K |
|
|
SPI
3614
DELISTED
SPI Energy Co., Ltd. Ordinary Shares
SPI
| $102K | ﹤0.01% |
118,966
+37,584
| +46% | +$32.2K |
|
3615
Redwire
RDW
$1.25B
| $101K | ﹤0.01% |
51,200
+19,000
| +59% | +$37.5K |
|
3616
Cadiz
CDZI
$315M
| $100K | ﹤0.01% |
+39,900
| New | +$100K |
|
3617
Xilio Therapeutics
XLO
$37.6M
| $100K | ﹤0.01% |
37,100
+8,600
| +30% | +$23.2K |
|
|
ADAG
3618
Adagene
ADAG
$109M
| $99K | ﹤0.01% |
74,600
-21,200
| -22% | -$28.1K |
|
3619
Elicio Therapeutics
ELTX
$188M
| $99K | ﹤0.01% |
12,170
-8,728
| -42% | -$71K |
|
|
FENG
3620
Phoenix New Media
FENG
$31M
| $99K | ﹤0.01% |
36,931
-11,200
| -23% | -$30K |
|
3621
Soleno Therapeutics
SLNO
$2.84B
| $99K | ﹤0.01% |
49,754
+4,800
| +11% | +$9.55K |
|
3622
Summit Therapeutics
SMMT
$14B
| $99K | ﹤0.01% |
+23,300
| New | +$99K |
|
3623
Eletrobras Preferred Shares
EBR.B
$20.4B
| $98K | ﹤0.01% |
11,968
-24,632
| -67% | -$202K |
|
3624
Quince Therapeutics
QNCX
$87M
| $98K | ﹤0.01% |
154,100
-180,125
| -54% | -$115K |
|
3625
TMC The Metals Company
TMC
$2.1B
| $98K | ﹤0.01% |
127,900
+13,900
| +12% | +$10.7K |
|